To test the relevance of CDADC1 in gemcitabine resistance in vivo, we used the KPC1245 (KPC) pancreatic cancer cell line, derived from Kras Trp53 mutant mice, which can form ectopic tumors and is used for preclinical studies (37). Here, KRAS is linked to pancreatic neoplasm.